Made In USAFor Laboratory Research OnlyCOAs Not Yet AvailableExplore Compound Research ProfilesCompare Catalog SizesResearch Requests Reviewed IndividuallyNot For Human Or Veterinary Use
WYZ LABS
0Account
Research blend

Wolverine+ with KPV

Catalog size
Price pending
USD per vial · Size pendingCatalog price
Research only

This formulation lists BPC-157, TB-500, MGF and KPV, with evidence limited to separate component studies and unresolved quantity and molecular-identity details.

Explore the research profile

Submit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.

No reservation or purchase is made by adding a material.
View documentation status ← Back to collection
Listed components
BPC-157 10 mg + TB-500 2.5 mg + MGF 1 mg + KPV (amount pending)
Format
Awaiting confirmation
Availability
Confirmed during review

Catalog quantities are not assay results.

In the literature

The components. The research context.

Four-component repair and inflammatory-signaling research blend

Understanding the formulation

Wolverine Plus + KPV adds the tripeptide lysine-proline-valine to the Wolverine Plus grouping. It is a four-component catalog name, not a molecule described by one amino-acid sequence. The KPV quantity and total formulation size are not confirmed. TB-500 and MGF additionally require precise sequence or construct documentation.

Reference identity
Research class
Four-component repair and inflammatory-signaling research blend
Catalog search names
Wolverine+ KPV BPC-157 TB-500 MGF

This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.

Why these components are studied

The component literature spans migration-related BPC-157 experiments, thymosin-related actin biology, disputed synthetic MGF E-peptide responses and KPV-associated intestinal inflammatory signaling. These arise from different tissues and experimental systems. Placing the compounds in one formulation does not establish that the pathways are compatible, that each component reaches its target or that their effects reinforce one another.

Component and related research

These links provide research context; they do not confirm the exact materials in this formulation.

Documented lines of inquiry

Research areas

  1. 01

    Repair-associated cellular responses

    BPC-157 experiments measured migration and survival in tendon-related systems. These observations concern an isolated experimental preparation, not a four-way blend. [1]

  2. 02

    Replication of E-peptide hypotheses

    The MGF literature includes independent work that failed to reproduce proposed proliferative effects. Mature IGF-1 activity and endogenous splice-variant expression should not be substituted for synthetic E-peptide evidence. [2]

  3. 03

    Experimental intestinal inflammation

    KPV studies examined transporter-linked uptake, cellular inflammatory pathways and mouse colitis. These model-specific findings do not establish an anti-inflammatory effect of the finished formulation in humans. [3]

Study topics describe the cited models, not established benefits of this catalog material.

Reading the evidence

What the studies
can tell us.

Component evidence · finished blend untested in cited studies

The cited studies provide a research context for individual components and highlight disagreement in the MGF evidence. They do not directly test this blend, its stability or a combined biological outcome. The incomplete specification further prevents a reliable comparison with any precisely characterized experimental preparation.

What remains uncertain

Do not infer the missing KPV quantity or total size. TB-500 fragment identity and the MGF construct need confirmation, and full-length protein findings should remain separately labeled. Component papers cannot establish finished-product purity, sterility, compatibility or clinical suitability.

Read the source

Selected literature

These papers concern individual components or related molecules. They do not validate this finished blend.

  1. 01PubMed
  2. 02PubMed
  3. 03
    2008 · Cell and animal study

    PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation (opens a new tab)

    PepT1 uptake and inflammatory signaling in cell systems, with mouse colitis experiments.

    PubMed

Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.

Before you begin

The details behind
the material.

Specifications and storage

Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.

Research use only

For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.

What to look for in a COA

Continue exploring.

All materials

Other research blends in the collection.

Research Blends

Wolverine

Wolverine pairs BPC-157 with a TB-500-listed component, connecting preclinical tendon and gastrointestinal research with thymosin-related identity questions. The exact TB-500 sequence still requires confirmation.

$65USD / vial · 10 mg
Research only
View details
Before you explore

Laboratory
research only.

Please confirm the following to enter the Wyz Labs collection.

Select both confirmations to continue.

Your acknowledgment is remembered for this browser session. This is a self-declaration, not identity verification.